1. Kumari, L.; Choudhari, Y.; Patel, P.; Gupta, GD.; Singh, D.; Rosenholm, JM.; Bansal, KK.; Kurmi, BD. Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs. Life. 2023, 13(5), 1099.
https://www.mdpi.com/2075-1729/13/5/1099.
2. Kumar; Hitesh.; Rajpoot.; Dr. Ashok Kumar.; Sharma.; Saurabh, Kumar.; Arvind. Solid Lipid Nanoparticles: A Strategy to Improve Oral Delivery of the Biopharmaceutics Classification System (BCS) Class II Drugs. International Journal of Pharmaceutical & Biological Archives 2018, 9(4), 204-215.
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3792762
3. Eltobshi, AA.; Mohamed, EA.; Abdelghani, GM.; Nouh, AT. Self-nanoemulsifying drug-delivery systems for potentiated anti-inflammatory activity of diacerein. Int J Nanomedicine. 2018, 13, 6585-6602. doi: 10.2147/IJN.S178819. PMID: 30425476; PMCID: PMC6202003.
https://www.tandfonline.com/doi/full/10.2147/IJN.S178819
4. Premakumar, SV.; B. A, Vishwanath.; Deepthi Swapna. Enhancement of Solubility and Dissolution Rate of BCS Class II Drugs. International Journal of Pharmaceutical Sciences Review and Research. 2024, 84(7), 153-161.
https://globalresearchonline.net/ijpsrr/v84-7/23.pdf
5. Agrawal, R.; Gupta, V. Cyclodextrins—a review on pharmaceutical application for drug delivery. Int J Pharm Front Res. 2012, 2(1), 95-112.
https://www.researchgate.net/publication/267381800_Cyclodextrins__A_Review_on_Pharmaceutical_Application_for_Drug_Deliver
6. Kumar, Nagabandi, V.; Ramarao, T.; Jayaveera, KN. Liquisolid compacts: a novel approach to enhance bioavailability of poorly soluble drugs. Int J Pharm Biol Sci. 2011, 1, 89-102.
https://ijpbs.com/ijpbsadmin/upload/ijpbs_50c826d8643ca.pdf
7. Dias, RJ.; Mali, KK.; Ghorpade, VS.; Havaldar, VD.; Mohite, VR. Formulation and evaluation of carbamazepine liquisolid compacts using novel carriers. Indian J Pharm Educ Res. 2017, 51(S2), S69-78.
https://www.researchgate.net/publication/314207751_Formulation_and_Evaluation_of_Carbamazepine_Liquisolid_Compacts_Using_Novel_Carriers
8. Nijhawan, M.; Santhosh, A.; Babu, PR.; Subrahmanyam, CV. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization. Drug Development and Industrial Pharmacy. 2013, 40(9), 1163-72. doi: 10.1590/s2175 97902022e191024.
https://www.tandfonline.com/doi/abs/10.3109/03639045.2013.804834.
9. Suryawanshi, VK.; Gidwani, B.; Verma, A.; Dubey, N.; Kaur, CD. Formulation and evaluation of ramipril liquisolid compact using novel carrier. Int J Pharm Sci Res. 2019, 10, 917-25.
https://ijpsr.com/bft-article/formulation-and-evaluation-of-ramipril-liquisolid-compact-using-novel-carrier/
10. Wankhede.; Navneet, B.; Walekar, SS.; Sadgir, PS.; Pawar, SA.; Ahirrao, SP. Liquisolid: A Novel Technique for Dissolution Enhancement of Poorly Water-Soluble Drugs. Asian Journal of Pharmaceutical Technology & Innovation. 2014, 2(08), 77-90.
https://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=3d36051065a9d2e98be014231521bfb8919115a4
11. El-Hammadi, M.; Awad, N. Investigating the use of liquisolid compacts technique to minimize the influence of pH variations on loratadine release. AAPS PharmSciTech. 2012, 13(1), 53-58. doi:10.1208/s12249-011-9719-6.
https://link.springer.com/article/10.1208/s12249-011-9719-6
12. Thakkar, HP.; Vasava, D.; Patel, AA.; Dhande, RD. Formulation and evaluation of liquisolid compacts of itraconazole to enhance its oral bioavailability. Therapeutic Delivery. 2020, 11(2), 83-96.
https://www.tandfonline.com/doi/abs/10.4155/tde-2019-0050
13. Spireas, S.; Bolton, M. (2002). Liquisolid systems and methods of preparing same. United States Patent. pp. 6423,339.
https://www.indianjournals.com/ijor.aspx?target=ijor:ajrps&volume=6&issue=3&article=004
14. Sai, PD.; Sivaiah, KV.; Bonthagarala, B.; Rao, PV. Review on liquisolid compact technology. World J Pharm Res. 2014, 4, 293-306.
https://wjpr.s3.ap-south-1.amazonaws.com/article_issue/1422699136.pdf
15. Nijhawan, M.; Godugu, M.; Saxena, T.; Farheen, T.; Dwivedi, K. Pharmaceutical co-crystals of posaconazole for improvement of physicochemical properties. Brazilian Journal of Pharmaceutical Sciences. 2022, 58, e191024. doi: 10.1590/s2175 97902022e191024
https://www.scielo.br/j/bjps/a/B8g53bk77QJKNmkZBz8fcYD/
16. Andrew EC, et al. Formulation and in Vitro Evaluation of Liquisolid Compact of Celecoxib. Mathews J Pharma Sci. 2024, 8(2), 31.
https://www.mathewsopenaccess.com/scholarly-articles/formulation-and-in-vitro-evaluation-of-liquisolid-compact-of-celecoxib.pdf
17. Patel, UB.; Modi, DC.; Shah, DP. Liquisolid compacts: A review. International Journal of Advances in Pharmaceutical. 2017, 6(7), 110-3.
https://core.ac.uk/download/pdf/335078044.pdf
18. Madhavi Harika Srimathkandala, Sushma M, Madhu Babu Ananthula, Vasudha Bakshi. forum Int J Pharm 2016; 6(2), 93-99.
https://www.pharmascholars.com/articles/formulation-and-evaluation-of-loperamide-liquisolid-compacts.pdf
19. Paulo, Costa.; Jose Manuel Sousa Lobo. Modeling and comparison of dissolution profiles, European Journal of Pharmaceutical Sciences, 2001,13(2), 123-133, ISSN 0928-0987. https://www.sciencedirect.com/science/article/abs/pii/S0928098701000951
20. Kassaye, L.; Genete, G. Evaluation and comparison of in-vitro dissolution profiles for different brands of amoxicillin capsules. African Health Sciences. 2013, 13(2), 369-375.
https://www.ajol.info/index.php/ahs/article/view/93524